Niederer Kraft Frey advised L-GAM on the deal. Vischer advised the seller. Wenger Vieli advised the shareholders of Cotta Collection. L-GAM, a mid-market private equity investment...
L-GAM and Peter Gschwend’s Investment into Cotta Group
Hangzhou GreatStar Industrial Co., Ltd.’s Listing on the SIX Swiss Exchange
Clifford Chance, Niederer Kraft Frey, Vischer and T&C Law Firm advised Hangzhou GreatStar Industrial Co., Ltd. on the deal. Allen & Overy advised the sole global...
Anokion’s $35 Million Equity Funding from Pfizer
Vischer advised Anokion in this transaction, while Walder Wyss advised Pfizer. Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune...
Lunaphore Technologies’ €10 Million Debt Financing
Vischer advised Norgine Ventures on the deal. Norgine Ventures has provided financing of approx. EUR 10 million to Lunaphore Technologies.The financing was realised in form of...
European Biotech Acquisition’s $200 Million Combination With Oculis
Davis Polk advised European Biotech Acquisition Corp. on the deal while Cooley and Vischer represented Oculis. European Biotech Acquisition Corp. (EBAC), a SPAC, signed its $200 million...
Genfit’s Acquisition of Versantis
VISCHER AG advised Versantis with Mark Fitzpatrick as CEO, Vincent Forster as CSO and Meriam Kabbaj as COO. Goodwin advised the sellers. Linklaters and Niederer Kraft...
Forty51 Ventures’ $43 Million Fundraising
VISCHER and Dechert advised Forty51 Ventures on the deal. FORTY51 Ventures, a Biotech venture capital firm, closed its first fund, FORTY51 Ventures Fund I SCSp, FIAR,...
Sunrise’s Acquisition of EBL’s Telecom Division
VISCHER advised EBL on the deal. Swiss full-service provider Sunrise has signed an agreement to acquire the telecom business of utility firm EBL. EBL has been...
Ningbo Shanshan’s $310.5 Million GDRs Issuance and Listing on The SIX Swiss Exchange
Vischer, Advestra and Grandway advised Ningbo Shanshan on the deal. Niederer Kraft Frey has advised the underwriters led by Huatai Financial Holdings (Hong Kong) Limited and...
Mosanna Therapeutics AG’s Seed Financing Round
VISCHER advised Mosanna Therapeutics AG on the deal. Mosanna Therapeutics AG, a Basel-based biotechnology company developing the advanced small molecule MOS118 (formerly know as AVE0118) for...
Valentino’s Opening of a New Geneva Boutique
VISCHER acted as legal counsel to Valentino. Valentino, the luxury Italian fashion house, will open a new Geneva boutique at prestigious rue du Rhône. Valentino’s CEO...
Novaremed’s Option and License Agreement With NeuroFront
VISCHER advised Novaremed AG on the deal. Novaremed AG, a privately held clinical-stage biopharmaceutical company and NeuroFront Therapeutics (Hong Kong) Limited, a China-based clinical stage neuroscience...